Arizona State University will pay Medical Marijuana patients $95 to participate in a study by a leading U.S. cannabis researcher [ tweet this ]. Participants have to sign on for a 10 hour study that takes place over the course of one week. The study will include a two hour lab visit and several surveys throughout the week.

What are they studying? ASU researcher Madeline Meier won’t divulge exactly what the ongoing study is trying to determine, but did broadly say the study is looking at the effects of different types of cannabis.



If this study is anything like her last album, it’ll be a hit 🎤. Some of Meier’s past work includes published studies showing long-term cannabis use in adults can cause a decline in IQ; another that claims the most serious health issue facing long term cannabis users is dental health; and another that claims adolescents 12-18 showed no sign of IQ loss when consuming cannabis short-term. Who cares? Besides the patients getting enough money to buy a few more grams of their favorite meds? Medical professionals. 😷



The lack of research on cannabis-based treatments is one of the most cited reasons medical professionals, even those in legal states, are hesitant to include cannabis in their treatment plans. The Schedule I classification of cannabis has historically made it difficult for researchers to study the plant. Meier’s ability to conduct continued research on cannabis is a sign of the changing times.